Dear Kite: With 2300% upside, we blazed an amazing trail
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
With the $12 billion Kite buyout now signed, sealed and delivered, CEO Arie Belldegrun has penned a thank-you note to everyone who helped along the way.
Here it is, in its entirety.
To My Kite Family –
For all of us, the Kite experience has been more than just an investment opportunity or a stepping stone in a professional career. Over the past eight years, Kite has become an integral part of our lives and a foundation from which hope became more than just an aspiration.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.